Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
Primary Purpose
COVID-19 Patients, Hypoxemic Respiratory Failure, Prone Position
Status
Completed
Phase
Not Applicable
Locations
Qatar
Study Type
Interventional
Intervention
PRONE POSITION
Sponsored by
About this trial
This is an interventional treatment trial for COVID-19 Patients
Eligibility Criteria
Inclusion Criteria: - All adults with suspected or confirmed COVID-19 and hypoxemia respiratory failure.
- SPO2 less than 94% or Oxygen requirment of more than 5 liters.
- Requiring oxygen therapy in Hospital< 24 hours
Exclusion Criteria:
- Clinical assessment for immediate intervention.
- PF<50
- SF<90
- RR>60bpm
- Hemodynamics instability with need for vasopressors.
- MSOF
- Age<18
- Pregnancy
- Impaired LOC, agitation or lack of cooperative patient.
- BMI>40
- Unstable spine or pelvis
- Abdominal wound
- Pnemothorax
- Any injury or illness that may be worsened or result in pain as a result of prone position.
- DNAR
- Any contraindicaton to prone position.
Sites / Locations
- Hamad Medical Corporation
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
PRONE
NO PRONE
Arm Description
Any combination of prone or side position for 3 hours, 3 times a day for 3 days.
Usual care
Outcomes
Primary Outcome Measures
Proportion of patients requiring escalation to NIV (CPAP or BIPAP) or IV in each group
To assess the potential for prone position to reduce the requirement for escalation of respiratory support.
Secondary Outcome Measures
Full Information
NCT ID
NCT04853979
First Posted
April 12, 2021
Last Updated
August 3, 2022
Sponsor
Hamad Medical Corporation
1. Study Identification
Unique Protocol Identification Number
NCT04853979
Brief Title
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
Official Title
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
May 16, 2021 (Actual)
Primary Completion Date
July 12, 2021 (Actual)
Study Completion Date
July 12, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hamad Medical Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigator hypothesis is that early implementation of early, awake prone position for patients with COVID-19 pneumonia requiring oxygen therapy will reduce the need for escalation of respiratory support. Escalation of respiratory support is defined as the need for respiratory support with HFNO, NIV or IV.
Detailed Description
The world health organization has designated the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) as an ongoing pandemic and a public health emergency of international concern. The disease is estimated to be severe in 20% of patients and about 5-10% will need critical care with respiratory support. ARDS is thought to be the main cause of respiratory failure in COVID-19 patients. Research is still ongoing to further elucidate the different ARDS subtypes that may exist in COVID-19. It is crucial to find new targets for treatment and support of COVID-19 patients with respiratory failure.
Prone positioning causes a substantial improvement in oxygenation that appear to persist after the patient is returned to a supine position. It has also been shown to have a significant mortality benefit in invasively ventilated ARDS patients. Observational studies have shown improvement in oxygenation with awake prone positioning in non-intubated patients with COVID-19 pneumonia. There is no published RCTs to date. It remains unclear whether prone positioning averts invasive or non-invasive ventilation, accelerates recovery, or reduces mortality. Similarly, there is no data on presumed viral pneumonia. Future studies are needed to identify the optimal indications for, duration of pronation, and assessment of response.
Hypothesis: The investigator hypothesis is that early implementation of early, awake pronation for patients with Covid19 pneumonia requiring oxygen therapy will reduce the need for escalation of respiratory support. Escalation of respiratory support is defined as the need for respiratory support with HFNO, NIV or IV Research participants: Adults 18 years and older with suspected or confirmed COVID-19 presenting to HMC with hypoxemic respiratory failure (PF<200 or SpO2 less than 94% on FiO2>=0.4 or =>5 lit/min O2)
Design: This is a non-blinded randomized controlled trial. Participants will be randomized to one of two study arms:
Intervention arm: Any combination of prone or side position (defined as any part of the anterior chest wall being in contact with the bed) for at least 3 hours and up to 16 hours per day during wakefulness. Patients will be asked to prone on three occasions: morning, afternoon and evening. Breaks of 30-120 min are allowed in sitting position or supine each 4 hours. Bed elevation of >30 degrees will be maintained unless otherwise requested by the patient. No control or intervention is made during sleep periods. Intervention will last for up to 3 days or until the patient achieves oxygen saturations of 94-98% on room air. Oxygen delivery may be via NC, HM, HFNC or NIV.
Control arm: Usual care (no Prone unless asleep and assumes this position spontaneously). The patient is able to adopt their preferred natural position. The bed will be elevated >30 degrees unless requested otherwise by the patient. However prone position may be used as rescue therapy if oxygen requirements are =>15 lit/min O2 or HFNC/NIV with FiO2 =>0.6 with O2 saturation less than 90% at the discretion of the treating physician.
Methods and outcomes:
Data will be analyzed for escalation of respiratory support within the first three days of the study. Escalation of respiratory support is defined as follows:
escalation from NP/HC/NRB to HFNO or NIV or IV
escalation from HFNO or NIV to IV Several secondary outcomes will be analyzed as well as outlined in outcomes section.
Based on previous studies of prone position in COVID-19 patients, anticipate an improvement in oxygenation and possible prevention of intubation with shorter mechanical ventilation times. Awake proning has been shown to be safe in local practice.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19 Patients, Hypoxemic Respiratory Failure, Prone Position
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
Prone position cannot be masked to any member in the trial
Allocation
Randomized
Enrollment
61 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PRONE
Arm Type
Experimental
Arm Description
Any combination of prone or side position for 3 hours, 3 times a day for 3 days.
Arm Title
NO PRONE
Arm Type
Active Comparator
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
PRONE POSITION
Intervention Description
Any combination of prone or side position for 3 hours, 3 times a day for 3 days
Primary Outcome Measure Information:
Title
Proportion of patients requiring escalation to NIV (CPAP or BIPAP) or IV in each group
Description
To assess the potential for prone position to reduce the requirement for escalation of respiratory support.
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - All adults with suspected or confirmed COVID-19 and hypoxemia respiratory failure.
SPO2 less than 94% or Oxygen requirment of more than 5 liters.
Requiring oxygen therapy in Hospital< 24 hours
Exclusion Criteria:
Clinical assessment for immediate intervention.
PF<50
SF<90
RR>60bpm
Hemodynamics instability with need for vasopressors.
MSOF
Age<18
Pregnancy
Impaired LOC, agitation or lack of cooperative patient.
BMI>40
Unstable spine or pelvis
Abdominal wound
Pnemothorax
Any injury or illness that may be worsened or result in pain as a result of prone position.
DNAR
Any contraindicaton to prone position.
Facility Information:
Facility Name
Hamad Medical Corporation
City
Doha
ZIP/Postal Code
3050
Country
Qatar
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
We'll reach out to this number within 24 hrs